Sara Lonardi

机构：Istituto Oncologico Veneto, Istituti di Ricovero e Cura a Carattere Scientifico · ORCID：0000-0002-7593-8138

发表论文 1227 篇 · 总被引 36958 次 · h-index 87

代表论文

• Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC (2026 · Clinical Cancer Research)
• Deciphering the Molecular Landscape of Squamous Cell Carcinoma of the Anal Canal: From Biology to Precision Oncology (2026 · Cancers)
• Universal Tumor Screening in Colorectal Cancer: Role of MMR Immunohistochemistry for Lynch Syndrome and Early-Onset CRC (2026 · Cancers)
• Performance and Clinical Benefit of Comprehensive Genomic Profiling of GI Tumors in a Comprehensive Cancer Center (2026 · JCO Precision Oncology)
• Dihydropyrimidine dehydrogenase modulates immune response to checkpoint inhibition in mismatch repair deficient/microsatellite instability-high colorectal cancer (2026 · Journal for ImmunoTherapy of Cancer)
• Squamous cell anal carcinoma: Current therapeutic approaches (2026 · Clinics and Research in Hepatology and Gastroenterology)